Company News: Sanofi-Aventis, Chattem, Allergan and Pacific Communications

Share this article:
Sanofi-Aventis completed its acquisition of Chattem, strengthening its presence in the US consumer healthcare market and bolstering its OTC switch capabilities. Chattanooga, TN-based Chattem will continue to be led by Zan Guerry, CEO, who will report to Sanofi-Aventis US president and CEO Greg Irace.
 
Allergan
named Pacific Communications agency of record for overactive bladder treatment Sanctura XR. The review resulted from a co-promotion agreement Allergan entered into with Quintiles whereby Quintiles will leverage its expertise in primary care to rapidly deploy a specialized sales for ce for the product while Allergan continues to target urology. Pacific will act as agency of record on both efforts.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.